RNA interference in mammalia cells by RNA-3′-PNA chimeras

International Journal of Molecular Sciences

Volumn 9, Issue 3, 2008, Pages 299-315

  Potenza, Nicoletta ^a   Moggio, Loredana ^a   Milano, Giovanna ^a   Salvatore, Vincenzo ^a   Di Blasio, Benedetto ^a   Russo, Aniello ^a   Messere, Anna ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Modified siRNA; Peptide nucleic acids; RNA; RNA interference; RNA PNA chimeras

Indexed keywords

NUCLEASE; PEPTIDE NUCLEIC ACID; RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CHIMERA; GENE SILENCING; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PROTEIN FUNCTION; RNA INTERFERENCE; SERUM;

MAMMALIA;

EID: 41649113305     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms9030299     Document Type: Article

References (46)

1. Fire, A.; Xu, S.; Montgomery, M.K.; Kostas, S.A.; Driver S.E.; Mello, C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391, 806-811.
2. Zamore, P.D; Tuschl, T.; Sharp, P.A.; Bartel, D.P. RNAi: doublestranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000, 101, 25-33.
3. Bernstein, E.; Caudy, A.A.; Hammond, S.M.; Hannon, G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001, 409, 363-366.
4. Martinez, J.; Patkaniowska, A.; Urlaub, H.; Lührmann, R.; Tuschl, T. Single-stranded antisense siRNAs target RNA cleveage in RNAi. Cell 2002, 110, 563-574.
5. Meister, G.; Landthaler, M.; Patkaniowska, A.; Dorsett, Y.; Teng, G.;Tuschl, T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell. 2004, 15, 185-197.
6. Liu, J.; Carmell, M.A; Rivas, F.V.; Marsden, C.G.; Thomson, J.M.; Song, J.J.; Hammond, S.M.; Joshua-Tor, L; Hannon, G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004, 305, 1437-1441.
7. Elbashir, S.M.; Harborth, J.; Lendeckel, W.;Yalcin, A; Weber, K.; Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411, 494-498.
8. Harborth, J.; Elbashir, S.M.; Vandenburgh, K.; Manninga, H.; Scaringe, S.A.; Weber, K.; Tuschl T. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 2003, 13, 83-105.
9. Elbashir, S. M.; Harborth, J.; Weber, K.; Tuschl, T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002, 26, 199-213.
10. Sullenger, B.A; Gilboa, E. Emerging clinical applications of RNA. Nature 2002, 418, 252-258.
11. Saulnier, A.; Pelletier, I.; Labadie, K.; Colbere-Garapin, F. Complete Cure of Persistent Virus Infections by Antiviral siRNAs. Molecular Therapy 2006, 13, 142-150.
12. Bitko, V; Musiyenko, A.; Shulyayeva, O.; Barik, S. Inhibition of Respiratory viruses by nasally administered siRNA. Nature Medicine 2005, 11, 31-36.
13. McCaffrey, A.P.; Nakai, H.; Pande, K.; Huang, Z.; Salazar, F.H.; Xu, H.; Wieland, S.F.; Marion, P.L.; Kay, M.A. Inhibition of hepatitis B virus in mice byRNA interference. Nature Biotechnol. 2003, 21, 639-644.
14. Dorsett, Y.; Tuschl, T. siRNAs:applications in functional genomics and potential therapeutics. Nat. Rev. Drug Discov. 2004, 3, 318-329.
15. Zhang, H.Y.; Du, Q.; Wahlestedt, C.; Liang, Z. RNA Interference with Chemically Modified siRNA. Curr. Top. Med. Chem. 2006, 6, 893-900.
16. Czauderna, F.; Fechtner, M.; Dames, S.; Aygucombining double acute accentn, H.; Klippel, A.; Pronk, G.J.; Giese, K. Kaufmann, J. Structural variations and stabilizing modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 2003, 31, 2705-2716.
17. Amarzguioui M.; Holen T.; Babaie E.; Prydz H. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 2003, 31, 589-595.
18. Chiu, Y.L.; Rana, T.M. siRNA function in RNAi: a chemical modification analysis. RNA 2003, 9, 1034-1048.
19. Manoharan, M. RNA interference and chemically modified small interfering RNAs. Current Opinion in Chemical Biology 2004, 8, 570-579.
20. Layzer, J.M.; McCaffrey, A.P.; Tanner, A.K.; Huang, Z.; Kay, M.A.; Sullenger, B.A.; In vivo activity of nuclease-resistant siRNAs. RNA 2004, 10, 766-771.
21. Parrish, S.; Fleenor, J.; Xu, S.; Mello, C.; Fire, A. Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol. Cell. 2000, 6, 1077-1087.
22. Braasch, D.A.; Jensen, S.; Liu, Y.; Kaur, K.; Arar, K.; White, M.A.; Corey, D.R. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 2003, 42, 7967-7975.
23. Elmen, J.; Thonberg, H.; Ljungberg, K.; Frieden, M.; Westergaard, M.; Xu, Y.; Wahren, B.; Liang, Z.; Orum, H.; Koch, T.; Wahlestedt, C. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 2005, 33, 439-447.
24. Hamada, M.; Ohtsuka, T.; Kawaida, R.; Koizuma, M.; Morita, K.; Furukawa, H.; Imanishi, T.; Miyagishi, M.; Taira, K. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3′-ends of siRNAs. Antisense Nucleic Acid Drug. Dev. 2002, 12, 301-309.
25. Dowler, T.; Bergeron, D.; Tedeschi, A.; Paquet, L.; Ferrari, N.; Damha, M.J. Improvements in siRNA properties mediated by 2′-deoxy-2′- fluoro-β-D-arabinonucleic acid (FANA). Nucleic Acids Res. 2006, 34, 1669-1675.
26. Dande, P.; Prakash, T.P.; Sioufi, N.; Gaus, H.; Jarres, R.; Berdeja, A.; Eric, E.; Swayze, E.E.; Griffey, R.H.; Bhat, B. Improving RNA interference in mammalian cells by 4'thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2′-O-alkyl modifications. J. Med. Chem. 2006, 49, 1624-1634.
27. Nykanen, A.; Haley, B.; Zamore, P.D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell. 2001, 107, 309-321.
28. Chiu, Y.L.; Ali, A.; Chu, C.; Cao, H.; Rana, T.M. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem. Biol. 2004, 11, 1165-1175.
29. Lorenz, C.; Hadwiger, P.; John, M.; Vornlocher, H. P.; Unverzagt, C. Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg. Med. Chem. Lett. 2004, 14, 4975-4977.
30. Egholm, M.; Nielsen, P.E.; Buchardt, O.; Berg, R.H. Recognition of guanine and adenine in DNA by cytosine and thymine containing peptide nucleic acids (PNA). J. Am. Chem. Soc. 1992, 114, 9677-9678.
31. Hyrup, B.; Nielsen, P. E. Peptide nucleic acid (PNA): synthesis, properties and potential applications. Bioorg. Med. Chem. 1969, 4, 5-23.
32. Komiyama, M.; Ye, S.; Liang, X.; Yamamoto, Y.; Tomita, T.; Zhou, J.M.; Aburatani, H. PNA for one-base differentiating protection of DANN from nuclease and ist use for SNP detection. J. Am. Chem. Soc. 2003, 125, 3758-3762.
33. Uhlmann, E.; Peyman, A.; Breipohl, G.; Will, D.W. PNA: synthetic polyamide nucleic acids with unusual binding properties. Angew. Chem., Int. Ed. 1998, 37, 2796-2823.
34. Uhlmann, E. Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function. Biol. Chem. 1998, 379, 1045-1052.
35. Capasso, D.; De Napoli, L.; Di Fabio, G.; Messere, A.; Montesarchio, D.; Pedone, C.; Piccialli, G.; Saviano, M. Solid phase synthesis of DNA-3′-PNA chimeras by using Bhoc/Fmoc PNA monomers. Tetrahedron 2001, 57(46), 9481-9486.
36. Esposito, V.; Randazzo, A.; Messere, A.; Galeone, A.; Petraccone, L.; Giancola, C.; Piccialli, G.; Mayol, L. Synthesis and structural characterization of PNA-DNA quadruplex forming chimeras. Eur. J. Org. Chem. 2003, 17, 3364-3371.
37. Petraccone, L.; Erra, E.; Messere, A.; Montesarchio, D.; Piccialli, G.; De Napoli, L.; Barone, G.; Giancola, C. Targeting duplex DNA with DNA-PNA chimeras? Physico-chemical characterisation of a triplex DNA-PNA/DNA/DNA. Biopolymers 2004, 73, 434-442.
38. Greiner, B.; Breipohl, G.; Uhlmann, E. (2′-O-Methyl-RNA)-3′- PNA Chimeras: A New Class of Mixed Backbone Oligonucleotide Analogues with High Binding Affinity to RNA. Helv. Chim. Acta 2002, 85, 2619-2626.
39. Turner, J.J.; Jones, S.; Fabani, M.M.; Ivanova, G.; Arzumanov, A.A.; Gait, M.J. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells, Molec. and Dis. 2007, 38, 1-7.
40. Van der Laan, C.; Havenaar, P.; Oosting, R.S.; Kuyl-Yheskiely, E.;Uhlmann, E.; van Boom, J.H. Bioorg. Med. Lett. 1998, 8, 663-668.
41. Breipohl, G.; Will, D.W.; Peyman, A.; Uhlmann, E. Novel synthetic routes to PNA monomers and PNA-DNA linker molecules. Tetrahedron 1997, 53(43), 14671-14686.
42. O'Toole, A.S.; Miller, S.; Serra, M.J. Stability of 3′ double nucleotide overhangs that model the 3′ ends of siRNA. RNA 2005, 11(4), 512-516.
43. O'Toole, A.S.; Miller, S.; Haines, N.; Zink, M.C.; Serra, M.J. Comprehensive thermodynamic analysis of 3′ double-nucleotide overhangs neighboring Watson-Crick terminal base pairs. Nucleic Acids Res. 2006, 34(11), 3338-3344.
44. Lingel, A.; Simon, B.; Izaurralde, E.; Sattler, M. Nucleic acid 3′-end recognition by the Argonaute 2 PAZ domain. Nat. Struct. Mol. Biol. 2004, 11, 576-577.
45. Ma, J.B.; Ye, K.; Patel, D.J. Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain. Nature 2004, 429, 318-322.
46. Muller, S.; Wolf, J.; Ivanov, S. A. Current strategies for the synthesis of RNA. Curr. Org. Synth. 2004, 1, 293-307.